NCT06544798
Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia
Enrolling by Invitation
PHASE2Ages 18+InterventionalTreatmentMeiraGTx, LLC
~276 participants
Updated 2025-10-16 on ClinicalTrials.gov
What's tested:AAV2-hAQP1
At a glance
Recruiting sites
0 of 8 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of participants with study drug-related adverse events and serious adverse events
Measured over From study start until Month 60 post-treatment
Conditions
Where it's being run
8 sites across 8 statesArizona1
Florida1
Iowa1
Missouri1
New York1
North Carolina1
Pennsylvania1
Ontario1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Received study drug in Study MGT-AQP1-201
Exclusion
Withdrew consent to participate in Study MGT-AQP1-201.
What this trial measures
- Number of participants with study drug-related adverse events and serious adverse eventsFrom study start until Month 60 post-treatment